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Psoriasis is an immune-mediated inflammatory disorder 
of the skin with a complex pathogenesis and a strong 
genetic component (1). Several regions in the genome, 
including the psoriasis susceptibility locus 1 (PSOR1), 
have been identified as conferring susceptibility to pso-
riasis (2–4). However, the complete genetic background 
of psoriasis remains to be established. Autophagy is a 
fundamental biological process that is involved in cell 
growth and plays a role in innate and adaptive immunity. 
In particular, autophagy-selective responses contribute 
to inflammatory bowel disease (IBD) (5, 6), neuro-
degeneration (7), and cancer (8). The ATG16L1 protein, 
which is encoded by the ATG16L1 gene (2q37), is a key 
component of a large protein complex essential for au-
tophagy (9), and polymorphisms within this gene have 
been reported to be associated with Crohn’s disease (5). 
Taking into consideration that genes in the autophagy 
pathway play an important role in inflammation and 
immunity, and as a part of our ongoing research on the 
impact of genetic variants to the risk of psoriasis vulga-
ris, the aim of the present study was to assess whether 
polymorphisms in ATG16L1 gene might also contribute 
to the risk of psoriasis.
MATeRIALS AnD MeThODS
A cohort of 241 unaffected controls (mean age 35.01 ± 13.60 
years, 131 females) with no personal or family history of pso-
riasis and 299 patients with plaque-type (non-pustular) psoriasis 
vulgaris (mean age 41.11 ± 13.87 years, age of onset 20.90 ± 8.16 
years, 132 females) of estonian origin were enrolled into a case 
control study. Clinical examination was performed at the outpa-
tient clinic in the Department of Dermatology and Venereology, 
University of Tartu. The ethics committee of the University of 
Tartu approved the study and informed consent was obtained 
from all participants. Six single nucleotide polymorphisms 
(SnPs) (rs10210302, rs12994971, rs2241880, rs2241879, 
rs7587633 and rs13005285) spanning a region of 36 Kb within 
the ATG16L1 gene were selected in our analysis, based on the 
criteria that SnPs had a minor allele frequency (MAF) > 5% 
in the Utah population of European descent (CEU) and had 
been validated. The polymorphic sites in the study except the 
rs2241880 SnP were genotyped using the SnPlex Genotyping 
System (Applied Biosystems, Foster City, CA, USA) according 
to manufactures’ instructions (10). The rs2241880 SNP was 
genotyped using the Taqman SnP 5´ allelic discrimination as-
say (Applied Biosystems) as reported previously (11). Logistic 
regression was used to obtain odds ratio (OR) values and Walds’ 
confidence intervals (CI) for alleles and genotypes using the 
R program (www.r-project.org). Linkage disequilibrium (LD) 
and haplotype analysis was performed using Shesis software 
(http://analysis.bio-x.cn/myAnalysis.php). A p-value of < 0.05 
was considered statistically significant for all analyses.
ReSULTS
no significant deviation from the hardy–Weinberg 
equilibrium in psoriasis or in the control group was 
observed (data not shown). The frequencies of alleles 
and genotypes are presented in Table I. The data ana-
lysis showed that the frequencies of the rs10210302 
CC (35.5% vs. 27.8%), rs12994971 CC (35.8% vs. 
27.8%), rs2241880 AA (36.5% vs. 27.8%), rs2241879 
GG (35.5% vs. 27.4%) and rs13005285 TT (19.4% vs. 
13.3%) were higher in psoriasis group compared with 
controls, respectively. Moreover, the frequency distribu-
tion (45.0% vs. 38.2%) of the rs13005285 T allele was 
significantly different (OR = 1.32, 95% CI = 1.03–1.69, 
p = 0.024). LD analysis of the ATG16L1 SnPs showed 
a highly significant association for each locus pair 
D´> 0.95 (data not shown). haplotype analysis of the 
ATG16L1 loci (rs10210302–rs12994971–rs2241880–
rs2241879–rs7587633–rs13005285) revealed 5 haplo-
types (frequency > 0.004) in both the affected and unaf-
fected subjects (Table II). In particular, the frequency 
distribution of the CCAGTT haplotype was higher 
(37.3 vs. 32.7%) in the psoriasis group compared with 
the controls; but it did not reach the level of statistical 
significance (Table II). On the other hand, the frequency 
distribution of the CCAGTG was significantly lower 
(OR = 0.20, 95% CI = 0.04–0.90, p = 0.021). 
DISCUSSIOn
We should take into account that, since the frequency 
distribution of the CCAGTG haplotype is low in our 
studied population, this might reflect that a larger cohort 
is required in order to be able to control our findings. 
Taking into consideration that the autophagy genes play 
an important role in the immune regulation including 
thymic selection, lymphocyte development and survi-
val, antigen presentation and tissue homeostasis (12), 
the autophagy pathway consequently has an impact in 
several immunological stimuli. Thus, we could spe-
culate that, since the ATG16L1 molecule is a member 
of this pathway, it probably also plays an important role 
in immune response, which needs further investigation. 
noticeably, it has been reported that defects in the 
ATG16L1 protein might result in reduced production of 
antimicrobial peptides by small-intestinal Paneth cells 
and increased production of secreted pro-inflammatory 
cytokines, including the IL-1β and IL18, by macro-
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phages, which might lead to intestinal inflammation 
(13, 14). Most recent, it has also been documented that 
dendritic cells from individuals with Crohn’s disease 
carrying a mutation in ATG16L1 gene are defective in 
autophagy, bacterial handling and antigen presentation 
(15). Hence, the latter evidence supports the notion 
of an important role of the ATG16L1 molecule in 
immune signalling and cell activation, and a putative 
role of ATG16L1 in susceptibility of psoriasis might 
also be considered. In particular, a possible defect in 
the ATG16L1 molecule might affect the autophagy 
machinery on signalling pathways that regulate cyto-
kine production and result in accumulation of damaged 
proteins and organelles that are toxic, leading to cell 
death, tissue damage and chronic inflammation. The 
precise mechanisms by which the disease-associated 
autophagy genes affect autophagy pathways are not 
yet known. however, elucidation of the function of the 
autophagy genes in the future may lead to potentially 
novel therapies for treating the diseases in which they 
are involved. 
In conclusion, to our knowledge the present study 
is the first report addressing a possible impact of the 
ATG16L1 gene on the risk of psoriasis. Meanwhile, 
additional molecular and functional studies in different 
ethnic groups will be required to ascertain the contribu-
tion of the ATG16L1 gene in psoriasis susceptibility.
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Table I. Genotype and allele frequency (%) distribution of ATG16L1 






(n = 299) OR (95% CI) p
rs10210302
CC 67 (27.8) 106 (35.5) 1a
CT 132 (54.8) 142 (47.4) 0.67 (0.46–1.00) 0.050
TT 42 (17.4) 51 (17.1) 0.76 (0.46–1.27) 0.30
C 266 (55.2) 354 (59.2) 1a
T 216 (44.8) 244 (40.8) 0.84 (0.66–1.08) 0.18
rs12994971
CC 67 (27.8) 107 (35.8) 1a
CT 132 (54.8) 142 (47.5) 0.67 (0.45–0.99) 0.045
TT 42 (17.4) 50 (16.7) 0.74 (0.44–1.24) 0.26
C 266 (55.2) 356 (59.5) 1a
T 216 (44.8) 242 (40.5) 0.83 (0.65–1.06) 0.15
rs2241880
AA 67 (27.8) 109 (36.5) 1a
AG 132 (54.8) 140 (46.8) 0.65 (0.44–0.95) 0.029
GG 42 (17.4) 50 (16.7) 0.73 (0.43–1.21) 0.23
A 266 (55.2) 358 (59.9) 1a
G 216 (44.8) 240 (40.1) 0.82 (0.64–1.05) 0.12
rs2241879
AA 42 (17.4) 50 (16.7) 0.74 (0.44–1.23) 0.25
AG 133 (55.2) 143 (47.8) 0.66 (0.45–0.98) 0.042
GG 66 (27.4) 106 (35.5) 1a
A 217 (45.0) 243 (40.6) 0.83 (0.65–1.06) 0.14
G 265 (55.0) 355 (59.4) 1a
rs7587633
CC 96 (39.8) 112 (37.5) 1a
CT 123 (51.1) 149 (49.8) 1.03 (0.72–1.49) 0.83
TT 22 (9.1) 38 (12.7) 1.48 (0.81–2.67) 0.19
C 315 (65.4) 373 (62.4) 1a
T 167 (34.6) 225 (37.6) 1.13 (0.88–1.46) 0.31
rs13005285
GG 89 (36.9) 88 (29.4) 1a
GT 120 (49.8) 153 (51.2) 1.28 (0.88–1.88) 0.18
TT 32 (13.3) 58 (19.4) 1.83 (1.08–3.09) 0.023
G 298 (61.8) 329 (55.0) 1a
T 184 (38.2) 269 (45.0) 1.32 (1.03–1.69) 0.024
aReferent estimate.
Table II. Haplotype frequency distribution of ATG16L1 






(n = 598) OR (95% CI) p
CCAGCG 15.2 13.9 0.89 (0.63–1.25) 0.52
CCAGCT 5.3 7.7 1.50 (0.91–2.47) 0.10
CCAGTG 1.8 0.4 0.20 (0.04–0.90) 0.021
CCAGTT 32.7 37.3 1.22 (0.95–1.57) 0.11
TTGACG 44.8 40.0 0.82 (0.64–1.04) 0.11
ars10210302–rs12994971–rs2241880–rs2241879–rs7587633–rs13005285.
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